The mechanics of injecting, sourced, not the dose

A shot under the skin (subcutaneous) puts the liquid into the layer of fat between the skin and the muscle. A shot into the muscle (intramuscular) goes deeper, through that fat and into the muscle itself. Muscle has a much richer blood supply. That difference in blood flow is the whole reason the route matters. Muscle soaks up a liquid faster than fat does. So a dose meant to be released slowly and evenly from the fat can act differently, and less predictably, if it lands in muscle by accident (PMID 25329935 , on why an insulin shot that lands in muscle by accident can get in faster and raise the risk of low blood sugar).

Every compound on this site sold to individuals, and this site's own reconstitution calculator, is built around the route buyers actually use: a shot under the skin, drawn up in an insulin syringe marked in U-100 units. Compound pages like BPC-157 and TB-500 say so. They also say plainly that no published study in people has given either one that way. A shot under the skin is the route the market uses. For most of the compounds on this site, it is not the route any study tested.

A shot under the skin is what the sites, needles and steps below describe. A shot into the muscle is a different, deeper procedure. It has its own landmarks and its own risks, mainly nerve damage when the spot is wrong (Source ). This page does not walk through it.

Four places on the body have enough fat over a big enough area for a shot under the skin: the belly, the outer thigh, the back of the upper arm, and the upper outer buttock (Source , Source ). What is underneath differs by site, and that decides how forgiving each one is.

This is one of the few claims on this page backed by more than theory. A 2026 review pooled 51 studies of people on insulin. It looked at lipohypertrophy, the fatty lump that forms under skin that gets injected again and again. Not moving the injection spot properly was the single strongest risk it measured. It came with roughly nine times the odds, compared with people who moved the spot properly (8.85 times). Reusing needles across several shots was the second strongest (3.20 times), ahead of more than five years on insulin and more than two shots a day (PMID 40109173 ).

The lump matters beyond looks. NHS patient guidance says plainly that injecting the same spot again and again causes a fatty lump. Medicine gets in more slowly and less predictably through it (Source ). That is the same kind of problem described above for a shot that lands in muscle by accident, just in the opposite direction.

The usual way to move the spot comes from the international TITAN guideline. It was built from 157 reviewed studies and checked by 127 experts across 27 countries. It is simple. Treat each of the four areas as its own zone. Move in a set pattern within a zone, not at random. Keep each shot at least one inch (about two and a half centimeters) from the last one in that zone (PMID 20933208 , Source ). Some patient guides suggest tracking sites with a written log or a small mark. That is because remembering where the last several shots went is harder than it sounds (Source ).

Gauge is how thick the needle is, and it runs backwards: a higher gauge number means a thinner needle. Insulin syringes are usually sold in the 28 to 31 gauge range. That is thin enough that thickness is rarely what makes a shot hurt. Length matters more. Insulin needles come in about 4 to 12.7 mm on pens and 6 to 12.7 mm on syringes (PMID 25329935 ). Length is what decides whether the shot actually stays in the fat layer.

Ultrasound scans of 388 adults measured this directly. A needle of 4 to 5 mm put straight in at 90 degrees reached the fat layer with very little risk of hitting muscle, in almost every adult tested. An 8 mm needle was the most common length worldwide when that study was done. Put in the same way, it had an estimated 25 percent chance of reaching muscle at the thigh and 9.7 percent at the belly. A 4 mm needle had 1.6 percent and 0.1 percent at the same sites (PMID 25329935 , PMID 20429833 ). That is the measured reason a short, thin insulin syringe is the standard tool, not a longer needle made for shots into muscle. It is sized to stop where the fat layer stops, in most adults, most of the time.

The standard way is a 90 degree angle, straight into the skin. The fat layer is often thin in a lean or muscular person, at the thigh, or on the back of the arm. There, a 45 degree angle, or pinching a fold of skin and fat away from the muscle first, lowers the chance of a longer needle landing in muscle. It does not remove it (Source , PMID 25329935 ). A thinner person is exactly where the measured risk of hitting muscle with a standard-length needle is highest. That is the opposite of the common belief that a thin person needs less care.

1. Wash your hands. Use soap and water before handling the vial, syringe or skin. This is the first and least exciting step in every medical injection guideline, for a reason. It is the biggest germ risk that is fully in your control.
2. Swab the vial top. Wipe the rubber top of the vial with an alcohol swab before putting a needle in. Do it every time, even on a vial you already opened. Site and vial care is one of the topics the TITAN guideline covers directly (PMID 20933208 ).
3. Swab the skin and let it dry. The WHO standard, looked at in a 2020 review of what works, is a 60 to 70 percent alcohol swab held on the skin for 30 seconds. Then let it air dry for 30 seconds before the needle goes in (PMID 33074639 ). Injecting through alcohol that is still wet carries it into the needle hole. That is a well known cause of a sharper sting going in, apart from anything in the syringe.
4. One needle, one use. The CDC rule for injection safety is one needle, one syringe, only one time. A used needle and syringe carry germs the moment they are used. They must be thrown away, not reused for a second draw, a second shot, or on a second person (Source ). There is also a physical reason. Poking the same rubber vial top again and again can cut tiny bits of rubber into the liquid. This is called coring. One study found it in 17.3 percent of pokes overall, worst with bigger needles. Insulin syringe needles are much thinner than the 18 to 21 gauge needles that study tested. That lowers the risk without removing it (PMID 35592659 ). Drawing and injecting with the same needle, across separate doses, combines both problems. Whatever touched the rubber top, or the outside world, on the draw goes under your skin on the shot.
5. Inject, then throw it away right away. The needle goes straight into a sharps container the moment it is out of the skin (covered in the section below). It does not go back in a drawer, a pocket, or anywhere it will be handled again before it is thrown away.

This is one of the most common questions in the search data. People ask it about specific compounds, including GHK-Cu, sermorelin and tesamorelin. The honest answer separates what injection pain research has shown from what users of these products only report, because nobody has run that second study.

What research shows. Bacteriostatic water is the mixing water this site's calculator assumes. It has 0.9 percent benzyl alcohol to keep germs from growing, and a pH of roughly 5.7 (labeled range 4.5 to 7.0). Its own FDA-approved label says both (Source ). A 2022 review looked at what makes injected growth hormone products hurt. It found that pH, temperature, how concentrated the liquid is, how thick it is, how much goes in, and how fast it goes in all add to injection pain. It also noted that the data behind this is limited and does not agree well across studies and products (PMID 36263321 ). Injecting into skin still wet with alcohol, instead of letting it air dry for the recommended 30 seconds, is also a known cause of extra sting going in (PMID 33074639 ). A cold liquid straight from the fridge makes the shot more uncomfortable. That was shown for insulin specifically. It is why many people keep the vial they are using at room temperature rather than in the fridge (Source ).

What people report, but no study has checked for these compounds. That pH, temperature and speed affect comfort is shown for the growth hormone products that were studied. GHK-Cu, sermorelin and tesamorelin have no published injection-pain study of their own. So using this to explain the sting people report after those is a guess based on a related kind of injected product. It is not a finding about those compounds. Patient guides widely teach that pushing the liquid in fast hurts more than going slowly. But this site found no study that measured injection speed against reported pain for any peptide it tracks. Treat that claim as believable and commonly taught, not as proven.

A small bruise from nicking a tiny blood vessel under the skin is common. So is mild redness that fades within a day, and a small firm spot that softens over a few days. They are common enough to be listed as expected reactions on the FDA-approved labels of injected drugs that have been well studied in people. Adalimumab's own patient leaflet lists redness, itching, bruising, pain or swelling where the shot went in. It says to mention them to a doctor only if they are bad or do not go away (Source ). A firm lump that grows over weeks of shots in the same spot is very likely lipohypertrophy, covered above. That calls for moving the spot, not a doctor visit on its own.

The reason to stop and see someone, rather than keep an eye on it, is a spot that is getting worse rather than better. Watch for redness that is clearly spreading past the injection point, red streaks running away from the spot, warmth, swelling or pain that is growing rather than fading, pus or any fluid leaking, or a fever. Together, those are the standard signs of a possible infection. If it has walled itself off, it may be an abscess, a pocket of pus. That is a known problem from a shot given without clean technique, or into skin that was already damaged (Source , Source ). None of that is something to wait out or treat with a forum thread. It needs a doctor or nurse in person. Telling a reaction that is settling down from an infection that is spreading takes someone who can actually look at the skin.

A used needle is medical waste. It carries the same risk of germs spread by blood, no matter what was in the syringe. The FDA is clear that a loose needle or syringe should never go into a household or public trash can or recycling bin, and should never be flushed. It puts trash and sewage workers, cleaners, family members and children at real risk of getting stuck (Source ).

The recommended option is an FDA-cleared sharps container, sold at most pharmacies. If you do not have one, the accepted backup is a heavy-duty plastic household container with a tight screw or snap lid that needles cannot easily poke through. Label it clearly, keep it upright, and keep it away from children and pets until it is full. A full container can usually be dropped off at a pharmacy, hospital, health department, or police or fire station. Some communities run mail-back or collection programs (Source ). Local rules on how a full sharps container may be thrown away differ by city and state. It is worth checking them rather than assuming any one method is allowed everywhere (Source ). Replace a needle the moment it is dull, bent, or has touched anything other than clean skin. Do not try to get one more use out of it. That is standard advice, for the same reasons covered in the keeping-it-clean section above (Source ).